ArticleJournal of gastrointestinal oncology2025
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between primary tumor resection and survival in metastatic intrahepatic cholangiocarcinoma: a retrospective cohort study based on the SEER database.Journal of gastrointestinal oncology · 2026Article
- Intrahepatic cholangiocarcinoma: the equity gap in one of the most lethal cancers.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intrahepatic cholangiocarcinoma (iCCA), the second most prevalent primary liver tumor, is associated with high mortality rates despite recent advances in treatment. The influence of socioeconomic factors on prognosis in iCCA remains understudied. Economic disparities among individuals under 65 years who are typically ineligible for Medicare, may influence healthcare outcomes. This study examines the effects of race and income in addition to common prognostic variables on the overall survival (OS) in patients with iCCA under 65 years. Methods: For this retrospective cohort study, data was extracted from the Surveillance, Epidemiology, and End Results (SEER) 22 database which included iCCA patients aged 20-64 years. The Kaplan-Meier analysis was applied to estimate the median survival time. Log rank test, univariate and multivariate Cox proportional hazards models were used to evaluate the association of age, ethnicity, income, and stage with OS. Results: A total of 8,585 iCCA patients were identified: Hispanic: 22%, non-Hispanic White 57%, Black 10%, Asian 10%, Native American 1%; 53% Males; median age was 57 years (range, 20-64 years) and median household income was $77,500 [interquartile range (IQR), $62,500-$92,500]. The estimated median OS (mOS) was 10 months [95% confidence interval (CI): 10-11]. Cancer stage was highly associated with survival, other significant prognostic factors were age and gender. Non-Hispanic Black (mOS: 8 months, 95% CI: 7-10) and Native American (mOS: 8 months, 95% CI: 5-15) patients had the poorest outcomes, followed by Hispanics (mOS 9 months, 95% CI: 8-10). Non-Hispanic White and Asian patients fared better (mOS 11 and 12 months, respectively) (P value <0.001). Patients with household income ≥$75,000 had better survival outcomes than those earning <$75,000 annually (P value <0.001). On multivariate Cox analysis, age <55 years, females, localized disease, Asian or Caucasian ethnicity, and median household income ≥$75,000 were independently associated with a lower risk of death. Conclusions: This study identifies ethnic and socioeconomic disparities in iCCA patients that may impact prognosis. These findings highlight the need for targeted interventions to address inequities, ensuring access to care and improving survival outcomes for underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.